(PRWEB) April 20, 2017
According to court documents filed by Marc J. Bern & Partners LLP, it is alleged that “Merck knew and had reason to know that its Zostavax vaccine was inherently defective and ... dangerous as designed,” and that “Merck downplayed the serious and dangerous side effects.” According to founding Partner Marc J Bern, the firm is currently representing nearly 5000 claimants and has thousands more filings to follow. “We have been investigating this drug for quite some time. We steadfastly believe in the merits of this litigation.“
About Marc J Bern
Mr. Bern has been at the forefront of pharmaceutical litigation for over 40 years. A nationally recognized law firm, Marc J. Bern & Partners LLP has been part of verdicts and settlements that have exceeded $ 3 Billion Dollars. Mr. Bern has been selected as one of “America’s Premier Lawyers” by Fortune Magazine and has been named one of the Top 100 Trial Lawyers by the National Trial Lawyers. He has been designated a New York Super Lawyer® every year since 2006. In 2007, he was honored to become a charter member of the Litigation Counsel of America. In addition, Mr. Bern has been selected as one of “America’s Premier Lawyers” by Fortune Magazine and has been named one of the Top 100 Trial Lawyers by the National Trial Lawyers.
With offices in five states Marc J. Bern & Partners LLP represents injury victims nationwide. Marc J. Bern & Partner LLP have both the fortitude and the resources to take on the well-funded pharmaceutical and medical device companies. To learn more about the Zostavax Litigation or to see if you may have a claim please contact Marc J. Bern & Partners LLP at 1-800-LAW-5432 or visit their website at http://www.bernllp.com.
To contact Mr. Bern directly call 1-516-361-4909
*Daniel Caudillo, et al. v. Merck & Co., Inc., et al. (Super. Ct. Alameda County, No. RG17857096.)
Barbara Gregory, et al. v. Merck & Co., Inc., et al. (Super Ct. L.A. County, No)
ATTORNEY ADVERTISING. Prior results do not guarantee or predict a similar outcome with respect to any future matter.